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1. Introduction 
Hageman factor, an intrinsic trigger of the sequence 
of proenzyme-enzyme transformations leading to 
blood coagulation [ 1,2], has been found to trigger 
off liberation of hypotensive polypeptides called 
plasma kinins [3]. We recently obtained evidence us- 
ing highly purified preparations that Hageman factor 
activates prekallikrein directly to kailikrein [4]. The 
activation was found to be of a catalytic nature [5], 
but no information has been obtained on the role of 
Hageman factor in the transformation of prekalli- 
krein to kallikrein. This paper reports evidence indi- 
cating that the conversion of prekallikrein to kalli- 
krein by Hageman factor may be accompanied by 
limited proteolysis of the precursor molecule. 
2. Materials and methods 
Prekallikrein was isolated from the pseudoglobulin 
fraction of bovine plasma as described previously [6]. 
Bovine Hageman factor was purified by the method 
of Komiya et al. [7], following its potency to acti- 
vate prekallikrein, and the preparation was charac- 
terized by determining its ability to correct the coagu- 
lation defect of Hageman factor-deficient human 
plasma [7]. SDS-polyacrylamide gel disc electro- 
phoresis was performed by the method of Shapiro 
et al. [8]. Gels were stained with 0.2 ‘% Coomassie 
Brilliant Blue in methanol-acetic acid-water 
(5: 1 :5, v/v/v) and excess dye was removed by dialysis 
against 7.5 5% acetic acid-5 5% methanol solution [o]. 
Carboxyl-terminal amino acid was determined by 
the selective tritium labelling method of Matsuo et al. 
[lOI. 
3. Results and discussion 
Fig. 1 shows the electrophoretic patterns of pre- 
kallikrein and kallikrein activated with Hageman 
factor on SDS-polyacrylamide gel disc electrophoresis. 
In the absence of /3-mercaptoethanol, they had the 
same mobility on the gel. This result supports our 
previous finding that the conversion of prekallikrein 
to kallikrein by Hageman factor does not involve a 
marked molecular change [5]. The electrophoretic 
mobility of prekallikrein on SDS-gel was also similar 
to that of prekallikrein treated with @-mercapto- 
ethanol, suggesting that prekallikrein may be com- 
posed of a single polypeptide chain. However, when 
kallikrein activated with Hageman factor was sub- 
jected to electrophoresis in the presence of /Lmercap- 
toethanol, the original protein band of kallikrein dis- 
appeared and new bands of rapidly migrating protein 
appeared. These results suggested that activation of 
prekallikrein was associated with limited proteolysis 
of peptide chains located between two cysteine 
residues which form the disulfide linkage in the pre- 
kallikrein molecule, just as observed on activation of 
plasminogen [ 111. 
To identify the C-terminal amino acid of prekalli- 
krein before and after activation by Hageman factor, 
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Fig. 1. SDS-polyacrylamide gel patterns of prekallikrein and 
kallikrein in the presence and absence of p-mercaptoethanol. 
Mixture containing bovine prekallikrein (30 pg) and bovine 
Hageman factor (1.7 pg) was incubated at 37” for 30 min. 
After incubation, the mixture or prekallikrein itself, with 
(+) or without (-) treatment with 0.1 M p-mercaptoethanol, 
was subjected to electrophoresis in 0.1 M phosphate buffer, 
pH 7.2, containing 0.1 % SDS, at 7 mA/tube for 4 hr. 
about 1 mg each of prekallikrein and kallikrein acti- 
vated with Hageman factor were treated separately 
with 50 mCi of tritium water in pyridine-acetic 
anhydride mixture, After standing for 12 hr at room 
temp., each mixture was dialyzed extensively against 
distilled water and lyophilized. The lyophilized 
material was hydrolyzed in an evacuated sealed tube 
with 6 N HCl at 105” for 24 hr. The hydrolyzate was 
then evaporated to dryness several times and finally 
dissolved in 0.2 ml of water. The sample was sub- 
jected to high voltage paper electrophoresis on Toyo 
filter paper No 5 1 A (30 X 60 cm) at 3000 V for 70 
min in pyridine-acetic acid buffer, pH 3.5. For 
measurement of radioactivity, the electropherogram 
was cut into small pieces and the radioactive material 
in each piece was extracted with 2 ml of 1% acetic 
Table 1 
Radioactive amino acids in hydrolyzates of prekallikrein and 
kallikrein after 3H-labelling 
Labelled amino acid Prekallikrein Kallikrein 
Aspartic acid 
Glutamic acid 
Leucine 
(Isoleucine) 
Arginine 
Lysine 
- Radioactivity (cpm) - 
2.5 67 
23 83.5 
141 177.5 
48.5 306.5 
25.5 106 
Mixture containing bovine prekallikrein (0.96 mg) and bovine 
Hageman factor (0.017 mg) was incubated at 36” for 4 hr. 
After incubation, the mixture of prekallikrein itself was tri- 
tuated by the method of Matsuo et al. [lo], and the labelled 
amino acid released after acid hydrolysis of the trituated 
proteins was separated, identified and counted. 
acid. The extract was evaporated to dryness, and its 
radioactivity was counted in 10 ml of scinti!lation 
fluid (5 g of 2,5-diphenyloxazole and 0.1 g of 1,4- 
bis(2-(4-methyl-5-phenyloxazolyl))benzene per 1 of 
toluene) with a Beckman liquid scintillation spec- 
trometer, model LS 25@. 
The radioactivity incorporated into prekallikrein 
was found to be mostly associated with the neutral 
amino acid region, but in case of kallikrein activated 
with Hageman factor, tritium was detected in the 
regions of neutral residues and arginine on the paper 
electropherogram (table 1). To identify the labelled 
neutral amino acid, the residues from vials corre- 
sponding to regions of neutral amino acids were 
washed several times with acetone and then dissolved 
in a minimum amount of water. These solutions were 
subjected to paper chromatography on Toyo filter 
paper No 5 1 A (30 X 60 cm) in a solvent system of 
pyridine-n-butanol-acetic acid-water (10: 15: 13: 12, 
by volume), with authentic specimens of neutral 
amino acids. The chromatogram was cut horizontally 
into 1 cm widths, and the radioactivity of each piece 
was determined with a liquid scintillation counter as 
described above. 
Leucine (isoleucine) was identified as the radio- 
active amino acid released from prekallikrein. Thus 
leucine (isoleucine) must be located at the C-terminal 
end of the molecule. However, with kallikrein acti- 
vated by Hageman factor, tritium was incorporated 
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predominantly into arginine besides the neutral 
amino acid observed with prekallikrein (table 1). 
These results suggest hat activation of prekalli- 
krein by Hageman factor is accompanied by a specific 
cleavage of the prekallikrein molecule, probably of a 
single arginyl peptide bond. The finding that an ar- 
ginine residue appeared as a new C-terminus during 
activation of prekallikrein may be correlated with the 
fact that bovine Hageman factor can hydrolyze a 
synthetic N-substituted arginine ester. Thus, the 
Hageman factor seems to function as a trypsin-like 
enzyme with restricted specificity. 
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